Gadobutrol injection
Products billed under this code include Gadavist, Gadobutrol.
Payment limit per 0.1 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Gadavist, Gadobutrol.
Payment limit per 0.1 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Gadavist | Bayer HealthCare Pharmaceuticals Inc. | 50419-0325-11 | 1500 | $352.50 |
| Gadavist | Bayer HealthCare Pharmaceuticals Inc. | 50419-0325-12 | 2000 | $470.00 |
| Gadavist | Bayer HealthCare Pharmaceuticals Inc. | 50419-0325-13 | 3000 | $705.00 |
| Gadavist | Bayer HealthCare Pharmaceuticals Inc. | 50419-0325-14 | 3000 | $705.00 |
| Gadavist | Bayer HealthCare Pharmaceuticals Inc. | 50419-0325-15 | 6500 | $1,527.50 |
| Gadavist | Bayer HealthCare Pharmaceuticals Inc. | 50419-0325-18 | 3000 | $705.00 |
| Gadavist | Bayer HealthCare Pharmaceuticals Inc. | 50419-0325-19 | 6500 | $1,527.50 |
| Gadavist | Bayer HealthCare Pharmaceuticals Inc. | 50419-0325-27 | 375 | $88.125 |
| Gadavist | Bayer HealthCare Pharmaceuticals Inc. | 50419-0325-28 | 500 | $117.50 |
| Gadavist | Bayer HealthCare Pharmaceuticals Inc. | 50419-0325-29 | 750 | $176.25 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Gadavist | Bayer HealthCare Pharmaceuticals Inc. | 50419-0325-37 | 300 | $70.50 |
| Gadobutrol | FreseniUS Kabi USA, LLC | 65219-0281-02 | 300 | $70.50 |
| Gadobutrol | FreseniUS Kabi USA, LLC | 65219-0281-07 | 1500 | $352.50 |
| Gadobutrol | FreseniUS Kabi USA, LLC | 65219-0281-10 | 2000 | $470.00 |
| Gadobutrol | FreseniUS Kabi USA, LLC | 65219-0281-15 | 3000 | $705.00 |
| Gadobutrol | FreseniUS Kabi USA, LLC | 65219-0287-30 | 3000 | $705.00 |
| Gadobutrol | FreseniUS Kabi USA, LLC | 65219-0289-65 | 6500 | $1,527.50 |
| Gadobutrol | Slate Run Pharmaceuticals | 70436-0212-54 | 1500 | $352.50 |
| Gadobutrol | Slate Run Pharmaceuticals | 70436-0212-80 | 75 | $17.625 |
| Gadobutrol | Slate Run Pharmaceuticals | 70436-0213-82 | 1000 | $235.00 |
| Gadobutrol | Slate Run Pharmaceuticals | 70436-0214-54 | 3000 | $705.00 |
| Gadobutrol | Slate Run Pharmaceuticals | 70436-0214-80 | 150 | $35.25 |
| Gadobutrol | Slate Run Pharmaceuticals | 70436-0216-51 | 1500 | $352.50 |
| Gadobutrol | Slate Run Pharmaceuticals | 70436-0217-50 | 650 | $152.75 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.235 | −$0.027 | 0.1 ML | Gadobutrol injection | v1, posted September 17, 2026 |
| 3Q26 | $0.262 | −$0.042 | 0.1 ML | Gadobutrol injection | v1, posted September 15, 2026 |
| 2Q26 | $0.304 | +$0.029 | 0.1 ML | Gadobutrol injection | v1, posted September 15, 2026 |
| 1Q26 | $0.275 | $0.00 | 0.1 ML | Gadobutrol injection | v1, posted September 15, 2026 |
| 4Q25 | $0.275 | +$0.012 | 0.1 ML | Gadobutrol injection | v1, posted September 8, 2026 |
| 3Q25 | $0.263 | −$0.001 | 0.1 ML | Gadobutrol injection | v1, posted March 10, 2026 |
| 2Q25 | $0.264 | −$0.014 | 0.1 ML | Gadobutrol injection | v1, posted March 10, 2026 |
| 1Q25 | $0.278 | +$0.004 | 0.1 ML | Gadobutrol injection | v1, posted December 19, 2025 |
| 4Q24 | $0.274 | −$0.036 | 0.1 ML | Gadobutrol injection | v1, posted June 11, 2025 |
| 3Q24 | $0.31 | −$0.037 | 0.1 ML | Gadobutrol injection | v1, posted June 11, 2025 |
| 2Q24 | $0.347 | +$0.003 | 0.1 ML | Gadobutrol injection | v1, posted March 11, 2025 |
| 1Q24 | $0.344 | +$0.02 | 0.1 ML | Gadobutrol injection | v1, posted December 19, 2024 |
| 4Q23 | $0.324 | −$0.021 | 0.1 ML | Gadobutrol injection | v1, posted October 10, 2024 |
| 3Q23 | $0.345 | +$0.005 | 0.1 ML | Gadobutrol injection | v1, posted June 5, 2024 |
| 2Q23 | $0.34 | +$0.008 | 0.1 ML | Gadobutrol injection | v1, posted February 23, 2024 |
| 1Q23 | $0.332 | −$0.012 | 0.1 ML | Gadobutrol injection | v1, posted December 6, 2023 |
| 4Q22 | $0.344 | +$0.013 | 0.1 ML | Gadobutrol injection | v1, posted June 22, 2023 |
| 3Q22 | $0.331 | +$0.009 | 0.1 ML | Gadobutrol injection | v1, posted June 9, 2023 |
| 2Q22 | $0.322 | −$0.024 | 0.1 ML | Gadobutrol injection | v1, posted December 14, 2022 |
| 1Q22 | $0.346 | −$0.035 | 0.1 ML | Gadobutrol injection | v1, posted June 8, 2022 |
| 4Q21 | $0.381 | +$0.031 | 0.1 ML | Gadobutrol injection | v1, posted June 2, 2022 |
| 3Q21 | $0.35 | −$0.003 | 0.1 ML | Gadobutrol injection | v1, posted June 2, 2022 |
| 2Q21 | $0.353 | −$0.01 | 0.1 ML | Gadobutrol injection | v1, posted March 1, 2022 |
| 1Q21 | $0.363 | – | 0.1 ML | Gadobutrol injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.